Related references
Note: Only part of the references are listed.HIV-1 accessory proteins - Ensuring viral survival in a hostile environment
Michael H. Malim et al.
CELL HOST & MICROBE (2008)
Soluble NKG2D ligands: prevalence, release, and functional impact
Helmut Rainer Salih
Frontiers in Bioscience-Landmark (2008)
Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells
Biswanath Majumder et al.
JOURNAL OF VIROLOGY (2008)
Lysis of endogenously infected CD4+T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals
Manuela Fogli et al.
PLOS PATHOGENS (2008)
DDB1 and Cu14A are required for human immunodeficiency virus type 1 vpr-induced G2 arrest
Lindi Tan et al.
JOURNAL OF VIROLOGY (2007)
The HIV1 protein vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor
Xiaoyun Wen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts
Jeffrey Ward et al.
BLOOD (2007)
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle
Kasia Hrecka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase
Jean-Philippe Belzile et al.
PLOS PATHOGENS (2007)
HIV-I Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system
Jason L. DeHart et al.
VIROLOGY JOURNAL (2007)
HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1
Baerbel Schroefelbauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers
Shigeki Hoshino et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase
Erwann Le Rouzic et al.
CELL CYCLE (2007)
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity
Cristina Cerboni et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo
Erik S. Zimmerman et al.
JOURNAL OF VIROLOGY (2006)
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
G Alter et al.
BLOOD (2005)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
QS Li et al.
NATURE (2005)
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
JJ Mattapallil et al.
NATURE (2005)
Characterization of CD56-/CD16+ natural killer (NK) cells:: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals
D Mavilio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system
Z Ao et al.
JOURNAL OF VIROLOGY (2004)
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
I Hickson et al.
CANCER RESEARCH (2004)
Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates
D Mavilio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells
K Levesque et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R
M Roshal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes
MI Bonaparte et al.
AIDS (2003)
Severe CD4(+) T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
M Guadalupe et al.
JOURNAL OF VIROLOGY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
HIV-1 Vpr displays natural protein-transducing properties: Implications for viral pathogenesis
MP Sherman et al.
VIROLOGY (2002)
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells
DA Eckstein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)